Skip to content

Strattice Reconstructive Tissue Matrix 0816001Recalls & reported problems

Lifecell Corporation · Strattice Reconstructive Tissue Matrix, 8 x 16, Pliable · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M32808160010), received between Aug 28, 2025 and Aug 28, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Abscess1
  • Cellulitis1
  • Post Operative Wound Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON 14/AUG/2025, PMQA RECEIVED NOTIFICATION FROM LEGAL THAT THE PLAINTIFF PROFILE FORM WAS RECEIVED ASSOCIATED WITH THIS EVENT. AS PER THE PPF FORM, THE PATIENT UNDERWENT AN ¿INCISIONAL HERNIA¿ SURGERY AND WAS IMPLANTED WITH TWO STRATTICE DEVICES ON (B)(6) 2018. THE PATIENT UNDERWENT AN ¿INCISION & DRAINAGE OF ABDOMINAL WALL ABSCESS, DEBRIDEMENT¿ ON (B)(6) 2019. THE PATIENT UNDERWENT AN ¿ABSCESS DRAINAGE/INCISION & DRAINAGE¿ ON (B)(6) 2021. THE PATIENT UNDERWENT AN ¿INCISION & DRAINAGE¿ ON (B)(6) 2021. THE PATIENT UNDERWENT A ¿NON-HEALING SUTURE ABSCESS, SUTURE REMOVAL, ABSCESS CAVITY DEBRIDED¿ ON (B)(6) 2021. THE FORM LISTS THE CONDITIONS THAT WERE TREATED WERE ¿OPEN INCISIONAL HERNIA REPAIR (2-LAYER SANDWICH MESH REPAIR WITH STRATTICE AND A PRIMARY FASCIA CLOSURE); ABSCESS CAVITY DEBRIDED¿ BETWEEN (B)(6) 2018 AND (B)(6) 2018. THE PATIENT WAS THEN TREATED FOR ¿INCISION & DRAINAGE OF ABDOMINAL WALL ABSCESS; DEBRIDEMENT¿ ON (B)(6) 2019. THE PATIENT RECEIVED TREATMENT FOR ¿ABDOMINAL WALL PAIN; ABDOMINAL WALL ABSCESS; ABSCESS DRAINAGE/INCISION & DRAINAGE¿ ON OR ABOUT (B)(6) 2021. THE PATIENT RECEIVED ¿INCISION & DRAINAGE; CHRONIC ABDOMINAL WOUND INFECTION; SUTURE ABSCESS (SUTURE CUT);

    Patient problems: Abscess; Cellulitis; Post Operative Wound Infection

    MAUDE report 22916210 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.